Ludwig Kappos

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 896 citations

Neurological Disorder, Clinical Neurology, Clinical Trials +9

Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue

Ulrich Roelcke, Ludwig Kappos, Jeannette Lechner‐Scott et al. · Neurology · 1997 · 472 citations

Fatigue Severity, Neurological Disorder, Frontal Cortex +22

Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis

Jens Kühle, Raija L.P. Lindberg, Axel Regeniter et al. · European Journal of Neurology · 2009 · 194 citations

Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results

Helmut Butzkueven, Ludwig Kappos, Fabio Pellegrini et al. · Journal of Neurology Neurosurgery & Psychiatry · 2014 · 171 citations · Full text

Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage

Massimo Filippi, Maria A. Rocca, Elisabetta Pagani et al. · Journal of Neurology Neurosurgery & Psychiatry · 2013 · 113 citations